Informed-money record
TERN · Terns Pharmaceuticals, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
12
Named actors
3
Disclosed $ (bull / bear)
$0 / $7.0M
Recent disclosures
12 of 12 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-03-16 | Chief Executive Officer Burroughs Amy L. | sold | $131K | SEC ↗ |
| 2026-03-16 | Chief Executive Officer Burroughs Amy L. | sold | $550K | SEC ↗ |
| 2026-02-17 | Chief Executive Officer Burroughs Amy L. | sold | $163K | SEC ↗ |
| 2026-02-17 | Chief Executive Officer Burroughs Amy L. | sold | $320K | SEC ↗ |
| 2026-02-17 | Chief Executive Officer Burroughs Amy L. | sold | $89K | SEC ↗ |
| 2026-01-15 | Chief Executive Officer Burroughs Amy L. | sold | $2.3M | SEC ↗ |
| 2026-01-15 | Chief Executive Officer Burroughs Amy L. | sold | $282K | SEC ↗ |
| 2026-01-05 | Chief Executive Officer Burroughs Amy L. | sold | $2.7M | SEC ↗ |
| 2026-01-02 | Chief Medical Officer Kuriakose Emil | sold | $37K | SEC ↗ |
| 2026-01-02 | Chief Medical Officer Kuriakose Emil | sold | $8K | SEC ↗ |
| 2025-11-04 | Director Quigley Jill M. | sold | $441K | SEC ↗ |
| 2025-10-01 | Chief Medical Officer Kuriakose Emil | sold | $7K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals